Exercise plus tirzepatide for muscle health in overweight adults
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at whether adding a structured exercise program to the weight-loss medication tirzepatide can improve muscle health and physical function in people who are overweight or obese. Participants will exercise while taking their usual medication, and the researchers will measure muscle quality and strength.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- Your body mass index (BMI) must be 27 or higher with a health condition, or 30 or higher.
- You must be currently taking tirzepatide (a weight-loss medication) prescribed by your doctor.
- You cannot have type 1 or type 2 diabetes.
- You cannot be currently following a structured diet or exercise program.
- You cannot have had surgery or injury to your arms or legs in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a weekly injection called tirzepatide can help people with COPD (chronic lung disease) breathe better and maintain muscle strength. It may also help with weight-related health problems.
This study tests a medication called tirzepatide (a type of GLP-1 drug) to see how it affects muscle and bone health during weight loss. It is for people with obesity who are not menopausal and do not have diabetes or bone disease.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
This study tests a new medication called tirzepatide, given at carefully adjusted doses, to help people with obesity lose weight while reducing unwanted side effects. Tirzepatide is a newer injectable medicine that helps control appetite and blood sugar.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.